Publications by authors named "Frederic Mallet"
Article Synopsis
- Radiotherapy dose escalation, specifically through the addition of high dose-rate brachytherapy (HDR-BB), has been shown to enhance biochemical control in patients with intermediate- to high-risk prostate cancer, as validated by this study involving 709 patients.* -
- After a median follow-up of 62 months, the results revealed a 5-year biochemical control rate of 87.5%, with 91% for intermediate-risk and 85% for high-risk categories, alongside high rates of clinical relapse-free survival and overall survival.* -
- The study concluded that HDR-BB is effective and well-tolerated when used with external beam radiotherapy, and suggests that integrating new hormonal treatments or refined fractionation regimens could
Purpose: To compare retrospectively the outcome of localized prostate cancers treated by curative external radiotherapy in which the negative lymphatic status was either surgically or radiologically assessed.
Methods And Materials: From January 1986 to December 1995, 112 patients with localized prostate cancers were found to have no evidence of lymphatic disease in the pelvis. N0 status was assessed either surgically (61 patients, group pN-) or after a CT scan procedure (51 patients, group cN0).